Insider Selling: Tetraphase Pharmaceuticals Major Shareholder Unloads 53,468 Shares of Stock (TTPH)
Tetraphase Pharmaceuticals (NASDAQ:TTPH) major shareholder Ventures Vi Lp Cmea unloaded 53,468 shares of Tetraphase Pharmaceuticals stock in a transaction dated Tuesday, September 17th. The shares were sold at an average price of $9.26, for a total value of $495,113.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Separately, analysts at Ladenburg Thalmann initiated coverage on shares of Tetraphase Pharmaceuticals (NASDAQ:TTPH) in a research note to investors on Wednesday, August 21st. They set a “buy” rating and a $13.00 price target on the stock.
Six investment analysts have rated the stock with a buy rating, Tetraphase Pharmaceuticals has a consensus rating of “Buy” and a consensus target price of $13.80.
Tetraphase Pharmaceuticals (NASDAQ:TTPH) traded up 8.33% on Wednesday, hitting $10.27. The stock had a trading volume of 404,456 shares. Tetraphase Pharmaceuticals has a 52-week low of $7.00 and a 52-week high of $10.85. The stock’s 50-day moving average is $8.70 and its 200-day moving average is $8.06. The company’s market cap is $212.3 million.
Tetraphase Pharmaceuticals, Inc, incorporated on July 7, 2006, is a clinical stage biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.